InvestorsHub Logo
Followers 0
Posts 13277
Boards Moderated 0
Alias Born 05/06/2016

Re: samsamsamiam post# 39563

Tuesday, 08/09/2016 3:13:28 AM

Tuesday, August 09, 2016 3:13:28 AM

Post# of 42929
Ken was wrong about MDIN's patent license.

I sent Ken another email and received the following reply in which he said he was mistaken - the license has not expired.

Subject: RE: Manzo Pharmaceuticals, Inc. Contact: Lacto-Freedom partner?
From: "Ken ." <manzopharma@
Date: Wed, July 13, 2016
--------------------------------------------------------------------------

I have no affiliation with Northstar so I can not confirm 400M shares paid to Celprogen.... You are correct about the license agreement not expiring. I recently reviewed it. The ORIGINAL draft was a period of 2 years. Celprogen's attorney updated it several times and I did not read the final draft. I am disappointed that nothing has happened with the probiotic and Northstar, but maybe now with human studies they will be interested again. Nicholas Chieco was the CEO I dealt with in the past and he is no longer there from what I understand.



If the MDIN ever acts on their patent license, MNZO would reap the royalty rewards.
But there would also be another lactose supplement competing with Lacto-Freedom.

No worries though, in 4 years MDIN hasn't accomplished a single thing as far as sales go. They don't have the brains or capital to organize a pissant's motorcycle trip around the inside of a Cheerio, let alone undertake a project like actually bringing a new product to market.